Target CEO Brian Cornell is stepping down next year after over a decade at the helm as the embattled retailer undertakes a high-stakes turnaround effort aimed at reigniting growth and reversing ...
The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...
Good morning. Target is shaking up its leadership team. The retailer continues to experience lagging sales and foot traffic, due in part to consumer pushback following a pullback on some of its DEI ...